Elsevier

Brain Research

Volume 784, Issues 1–2, 16 February 1998, Pages 57-62
Brain Research

Research report
Agonist-induced desensitization of adenylyl cyclase activity mediated by 5-hydroxytryptamine7 receptors in rat frontocortical astrocytes

https://doi.org/10.1016/S0006-8993(97)01185-2Get rights and content

Abstract

Our previous study has demonstrated that astrocytes derived from the rat frontal cortex contain 5-hydroxytryptamine (5-HT)7 receptors positively coupled to adenylyl cyclase. In this study, we observed a desensitization of 5-HT7 receptors induced by a treatment with agonists (0.1, 1, and 10 μM, 0.5 to 3.5 h). Maximum responses, but not the EC50 values, in the concentration–response curve of 5-HT-induced cyclic AMP formation were decreased after pretreatment with 5-HT. Pretreatment with 5-carboxamidotryptamine (5-CT) elicited a potent desensitization of 5-HT-induced cyclic AMP formation. Neither 2-methyl-5-HT nor α-methyl-5-HT caused the desensitization. When the astrocytes were treated with isoproterenol, N-ethylcarboxamidoadenosine, and dibutyryl cyclic AMP (all of which increase intracellular cyclic AMP levels), 5-HT-induced cyclic AMP responses were not affected. Conversely, adenylyl cyclase activity mediated by either isoproterenol or N-ethylcarboxamidoadenosine was attenuated by pretreatment with each of these agonists, but not 5-HT. In addition, our study showed that the administration of 5-HT, 5-CT, and 8-hydroxy-2-(di-n-propylamino)tetralin to the astrocytes stimulated cyclic AMP formation both in the presence and absence of forskolin, whereas in neuron-rich cultures of the frontal cortex, these agonists did not change basal cyclic AMP levels and decreased forskolin-stimulated cyclic AMP formation. Neurons may predominantly contain 5-HT1A receptors that are negatively coupled to adenylyl cyclase. These results suggest that 5-HT7 receptors are highly expressed in astrocytes but not in neuronal cells, and that pretreatment with their agonists results in a homologous desensitization of the receptors.

Introduction

5-Hydroxytryptamine (5-HT) receptor subtypes have been classified by operational, transductional, and structural criteria into seven major groups 6, 10. The most recent addition of the classification is the 5-HT7 receptor, which has been cloned in the rat 9, 13, 14, mouse [12], guinea-pig [18], and in humans [2]. These receptors contain seven predicted transmembrane domains and are positively coupled to adenylyl cyclase activation 9, 13, 14. Messenger RNA for 5-HT7 receptors has been detected in high abundance in the hypothalamus, thalamus, cortex, hippocampus, and other limbic areas 5, 9, 13, 14, 18. The functional significance of 5-HT7 receptors in the central nervous system, however, is not fully understood.

In a previous study we used reverse transcription and polymerase chain reaction (RT–PCR) to demonstrate that cultured astrocytes derived from the rat frontal cortex express 5-HT7 receptors and that the addition of serotonergic agonists to the astrocytes elicits the activation of adenylyl cyclase [17]. The rank order of efficacy of the agonists on cyclic AMP formation was: 5-carboxamidotryptamine (5-CT)>5-HT>5-methoxytryptamine (5-MeOT). This is in agreement with other mammalian cell culture experiments 13, 14, 18. In addition, cyclic AMP formation induced by 5-HT was inhibited by methiothepin, a potent inhibitor of 5-HT7 receptors, but not the antagonists of 5-HT1, 5-HT2, 5-HT3, and 5-HT4 receptors [17]. Conversely, we have found that the administration of 5-HT to neuron-rich cultures of the rat frontal cortex did not undergo any changes in cyclic AMP levels (unpublished data). It is possible that 5-HT7 receptors are selectively and/or abundantly expressed in astrocytes, rather than in other brain cells, and may be involved in astroglial function. We are the first to observe and compare the effects of serotonergic agonists on adenylyl cyclase activation in astrocytes and neuron-rich cultures derived from the rat frontal cortex. The administration of 5-HT increased cyclic AMP formation in astrocytes and decreased cyclic AMP formation in neuron-rich cultures.

Several investigators have characterized the homologous desensitization of G protein-coupled receptors, such as β2-adrenergic receptors, muscarinic acetylcholine receptors, and 5-HT2 receptors 3, 7, 8, 11, 19. It has been shown that the mechanisms of the desensitization process induced by agonists are involved in several different phenomena such as the phosphorylation of receptors by either protein kinase A (PKA), protein kinase C (PKC), or a certain receptor kinase, the sequestering of receptors to an internal compartment, and the modulation of receptor expression. Recently, it has been reported that the 5-HT4 and 5-HT6 receptor subtypes, which are positively coupled to adenylyl cyclase, are desensitized by pretreatment with serotonergic agonists in mouse colliculi neurons [1]and in neuroblastoma NCB.20 [4]. The present study examined whether 5-HT7 receptors are desensitized by agonists by investigating the effects of pretreatment with serotonergic agonists on 5-HT7 receptor-mediated adenylyl cyclase activation in astrocytes. Our results suggest that 5-HT7 receptors undergo homologous desensitization by their agonists in a time- and concentration-dependent manner.

Section snippets

Materials

5-HT hydrochloride and isoproterenol hydrochloride were obtained from Sigma Chemical (St. Louis, MO, USA). 5-CT, 5-MeOT, 2-methyl-5-HT, α-methyl-5-HT, 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), N-ethylcarboxamidoadenosine (NECA), and phorbol 12-myristate 13-acetate (PMA) were obtained from Research Biochemicals (Natick, MA, USA). Forskolin and staurosporine were obtained from Wako Pure Chemical (Osaka, Japan). Dibutyryl cyclic AMP was obtained from Yamasa (Chiba, Japan). N-[2-(p

Differences in serotonergic agonist-mediated cyclic AMP responses in astrocytes and in neuron-rich cultures

The addition of 5-HT and 5-CT (1 and 10 μM) increased cyclic AMP levels in astrocytes by 5- to 7-fold. 5-HT synergistically activated cyclic AMP formation in the presence of 1 μM forskolin. Similarly, 8-OH-DPAT led to a slight elevation of basal cyclic AMP levels and significantly increased forskolin-stimulated cyclic AMP formation (Fig. 1). In contrast, neither 5-HT, 5-CT, nor 8-OH-DPAT significantly affected basal cyclic AMP levels in neuron-rich cultures, even at concentrations of 10 μM;

Discussion

In the present study, the administration of 5-CT and 5-HT to rat frontocortical astrocytes potently increased cyclic AMP formation. 8-OH-DPAT slightly increased basal cyclic AMP levels and significantly enhanced forskolin-stimulated cyclic AMP formation. In contrast, the administrations of these agonists to neuron-rich cultures failed to change basal cyclic AMP levels and decreased forskolin-stimulated cyclic AMP formation. 8-OH-DPAT is a well-known agonist of 5-HT1A receptors. 5-HT1A receptors

References (19)

There are more references available in the full text version of this article.

Cited by (19)

  • Functional expression of 5-HT<inf>7</inf> receptor on the substantia gelatinosa neurons of the trigeminal subnucleus caudalis in mice

    2014, Brain Research
    Citation Excerpt :

    Further studies are needed to clarify the mechanism of 5-HT7 receptor-induced depolarization in the SG neurons of the Vc. Prolonged exposure to agonists results in desensitization of 5-HT7 receptor-mediated cyclic AMP formation in frontocortical astrocytes (Shimizu et al., 1998). Single or repeated systemic administration of 5-HT7 receptor antagonist SB 269970 decreases 5-HT7 receptor-mediated enhancement of the bursting activity in hippocampal slices (Tokarski et al., 2012).

  • Antidepressants act on glial cells: SSRIs and serotonin elicit astrocyte calcium signaling in the mouse prefrontal cortex

    2011, Journal of Psychiatric Research
    Citation Excerpt :

    The modulated serotonin-induced response might principally be explained by either the internalization of 5-HT receptors after glutamatergic stimulation or by intracellular modification of 5-HT receptors. A desensitization of a 5-HT7-mediated cAMP-rise in cultured astrocytes has been described before (Shimizu et al., 1998). The modulation of astrocytic neurotransmitter-induced responses by a second neurotransmitter has been described for the glutamate–acetylcholine signaling system at Schaffer collateral synapses in the hippocampus (Perea and Araque, 2005).

  • Biphasic regulation of mammary epithelial resistance by serotonin through activation of multiple pathways

    2008, Journal of Biological Chemistry
    Citation Excerpt :

    Previously, we reported the presence of only the 5-HT7 class of receptors in human and mouse mammary epithelium, correlatively implicating 5-HT7 as the mediator of 5-HT actions on tight junctions (21). 5-HT7 is a Gs-coupled receptor, with a high constitutive activity, which results in homologous desensitization (23–25). Blocking this constitutive activity by inverse agonists, such as metergoline or SB 269970, has been shown to resensitize the receptor (25, 36).

  • Glycogen metabolism in rat ependymal primary cultures: Regulation by serotonin

    2005, Brain Research
    Citation Excerpt :

    Of the remaining two receptors, 5-HTR 6 is less likely to be the recipient of the 5-HT signal since it is much less susceptible to the action of the agonist 5-CT [38,51], which elevated the cAMP level even more than 5-HT. Furthermore, agonist-induced desensitization which has been described for 5-HTR 7 [18,52] but not for 5-HTR 6 was observed. Therefore, the receptor-mediating 5-HT-dependent glycogenolysis seems to be 5-HTR 7, which is coupled to adenylyl cyclase via a stimulatory G protein [51].

  • 5-HT<inf>7</inf> receptors: Current knowledge and future prospects

    2000, Trends in Pharmacological Sciences
    Citation Excerpt :

    In this respect, it is important to note that the human 5-HT7(d) isoform has two extra phosphorylation consensus sites5. The 5-HT7 receptor appears to be subject to desensitization45, but different isoforms have not been investigated in this respect. The structural differences in the C-termini of the 5-HT7 receptor splice variants also indicate potential differential interactions with PDZ-domain-containing proteins8,20.

View all citing articles on Scopus
1

Present address: Department of Pharmacology, University of Washington, Seattle, WA 98195, USA.

View full text